FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Eagle Pharmacy, Inc.(038598540)" | 69852-691 | 69852-691-10 | Triamcinolone Acetonide | 50 mg/50 mg | 2021-1 | valid | 2026-11-12 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-776 | 69852-776-10 | Dexamethasone Acetate Anhydrous | 8 mg/8 mg | 2021-1 | valid | 2026-11-12 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 30 mg/30 mg | 2021-1 | valid | 2026-11-12 | ||
| "Exela Pharma Sciences, LLC.(831274399)" | 51754-9131 | 51754-9131-1 | Midazolam Hydrochloride | 100 mg/100 mL | 2021-1 | valid | 2026-11-12 | ||
| "Exela Pharma Sciences, LLC.(831274399)" | 51754-9131 | 51754-9131-5 | Midazolam Hydrochloride | 100 mg/100 mL | 2021-1 | valid | 2026-11-12 | ||
| "Exela Pharma Sciences, LLC.(831274399)" | 51754-9904 | 51754-9904-1 | Potassium Acetate | 200 meq/100 mL | 2021-1 | valid | 2026-11-12 | ||
| "Exela Pharma Sciences, LLC.(831274399)" | 51754-9160 | 51754-9160-1 | Fentanyl Citrate | 5000 ug/100 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-036 | 71506-036-01 | Atropine Sulfate | .4 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | 4 mg/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 8 mg/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | 32 mg/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-012 | 71506-012-55 | Ondansetron Hydrochloride | 8 mg/50 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-028 | 71506-028-59 | Oxytocin | 30 U/500 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-024 | 71506-024-58 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-044 | 71506-044-58 | Phenylephrine Hydrochloride | 300 mg/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-053 | 71506-053-58 | Phenylephrine Hydrochloride | 300 mg/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-040 | 71506-040-10 | Phenylephrine Hydrochloride | 400 ug/10 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-026 | 71506-026-51 | Phenylephrine Hydrochloride | 400 ug/5 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-008 | 71506-008-58 | Phenylephrine Hydrochloride | 80 mg/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-099 | 71506-099-05 | Rocuronium Bromide | 50 mg/5 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-034 | 71506-034-05 | Succinylcholine Chloride | 100 mg/5 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-079 | 71506-079-56 | Thiamine Hydrochloride | 500 mg/100 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-014 | 71506-014-58 | Vancomycin Hydrochloride | 750 mg/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-015 | 71506-015-58 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-016 | 71506-016-59 | Vancomycin Hydrochloride | 1.5 g/500 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | 1.75 g/500 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-018 | 71506-018-58 | Vancomycin Hydrochloride | 1 g/250 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-019 | 71506-019-59 | Vancomycin Hydrochloride | 2 g/500 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-020 | 71506-020-56 | Calcium Gluconate | 1 g/100 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-021 | 71506-021-56 | Calcium Gluconate | 2 g/100 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-022 | 71506-022-35 | Ephedrine Sulfate | 15 mg/3 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-035 | 71506-035-56 | Acyclovir Sodium | 200 mg/100 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-023 | 71506-023-03 | Glycopyrrolate | .6 mg/3 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-066 | 71506-066-10 | Lidocaine Hydrochloride | 100 mg/10 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 10 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 100 mg/5 mL | 2021-1 | valid | 2026-11-12 | ||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | .8 mg/.8 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2 mg/.165 g; 25 mg/.165 g; 3 mg/.165 g | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 25 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate | .75 mg/1 mL; 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 |